YOUR BUSINESS AUTHORITY
Springfield, MO
Life science company MilliporeSigma is expanding in St. Louis with a $76 million investment.
The plans include 170 new jobs as the company expands the capabilities of an existing St. Louis plant to manufacture cancer drugs.
The investment is expected to triple the facility's production capacity for antibody-drug conjugate manufacturing.
Read more from the St. Louis Business Journal.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year